Pharmacokinetic studies of new silver-based complex

Vladimir Silnikov, Evgenii Plotnikov, Vladimir Plotnikov

Результат исследований: Материалы для журналаСтатья

5 Цитирования (Scopus)

Выдержка

Objective: Investigation of pharmacokinetics parameters of the new silver-based compound of general formula C6H19Ag2N4LiO6S2, called “Argosil”, with high antiviral activity. Methods: Water solution of complex administered intragastrically in the dose rate of 100 mg/kg body weight of mice BALB/c (males) aged 1.5-2.0 mo. Blood and tissues samples analyzed by mass spectrometry. Results: Half-life of the drug was about 4 h at the initial stage. About 5% of the initially introduced silver detected after 24 h. Maximum drug concentration observed in the lung tissues. Conclusion: Results make the basis for further test and clinical implementation. Taken into account low toxicity and antiviral properties of this compound, it looks especially effective for lung infections treatment.

Язык оригиналаАнглийский
Страницы (с-по)41-43
Число страниц3
ЖурналInternational Journal of Pharmacy and Pharmaceutical Sciences
Том7
Номер выпуска6
СостояниеОпубликовано - 2015

Отпечаток

Silver
Antiviral Agents
Silver Compounds
Pharmacokinetics
Lung
Pharmaceutical Preparations
Half-Life
Mass Spectrometry
Body Weight
Water
Infection

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Цитировать

Pharmacokinetic studies of new silver-based complex. / Silnikov, Vladimir; Plotnikov, Evgenii; Plotnikov, Vladimir.

В: International Journal of Pharmacy and Pharmaceutical Sciences, Том 7, № 6, 2015, стр. 41-43.

Результат исследований: Материалы для журналаСтатья

Silnikov, Vladimir ; Plotnikov, Evgenii ; Plotnikov, Vladimir. / Pharmacokinetic studies of new silver-based complex. В: International Journal of Pharmacy and Pharmaceutical Sciences. 2015 ; Том 7, № 6. стр. 41-43.
@article{b94662b439d14c0f85e0dbda3ae08820,
title = "Pharmacokinetic studies of new silver-based complex",
abstract = "Objective: Investigation of pharmacokinetics parameters of the new silver-based compound of general formula C6H19Ag2N4LiO6S2, called “Argosil”, with high antiviral activity. Methods: Water solution of complex administered intragastrically in the dose rate of 100 mg/kg body weight of mice BALB/c (males) aged 1.5-2.0 mo. Blood and tissues samples analyzed by mass spectrometry. Results: Half-life of the drug was about 4 h at the initial stage. About 5{\%} of the initially introduced silver detected after 24 h. Maximum drug concentration observed in the lung tissues. Conclusion: Results make the basis for further test and clinical implementation. Taken into account low toxicity and antiviral properties of this compound, it looks especially effective for lung infections treatment.",
keywords = "Antiviral drug, Argosil, Mass spectrometry, Pharmacokinetics, Silver distribution in tissues, Silver-based complex",
author = "Vladimir Silnikov and Evgenii Plotnikov and Vladimir Plotnikov",
year = "2015",
language = "English",
volume = "7",
pages = "41--43",
journal = "International Journal of Pharmacy and Pharmaceutical Sciences",
issn = "0975-1491",
publisher = "IJPPS",
number = "6",

}

TY - JOUR

T1 - Pharmacokinetic studies of new silver-based complex

AU - Silnikov, Vladimir

AU - Plotnikov, Evgenii

AU - Plotnikov, Vladimir

PY - 2015

Y1 - 2015

N2 - Objective: Investigation of pharmacokinetics parameters of the new silver-based compound of general formula C6H19Ag2N4LiO6S2, called “Argosil”, with high antiviral activity. Methods: Water solution of complex administered intragastrically in the dose rate of 100 mg/kg body weight of mice BALB/c (males) aged 1.5-2.0 mo. Blood and tissues samples analyzed by mass spectrometry. Results: Half-life of the drug was about 4 h at the initial stage. About 5% of the initially introduced silver detected after 24 h. Maximum drug concentration observed in the lung tissues. Conclusion: Results make the basis for further test and clinical implementation. Taken into account low toxicity and antiviral properties of this compound, it looks especially effective for lung infections treatment.

AB - Objective: Investigation of pharmacokinetics parameters of the new silver-based compound of general formula C6H19Ag2N4LiO6S2, called “Argosil”, with high antiviral activity. Methods: Water solution of complex administered intragastrically in the dose rate of 100 mg/kg body weight of mice BALB/c (males) aged 1.5-2.0 mo. Blood and tissues samples analyzed by mass spectrometry. Results: Half-life of the drug was about 4 h at the initial stage. About 5% of the initially introduced silver detected after 24 h. Maximum drug concentration observed in the lung tissues. Conclusion: Results make the basis for further test and clinical implementation. Taken into account low toxicity and antiviral properties of this compound, it looks especially effective for lung infections treatment.

KW - Antiviral drug

KW - Argosil

KW - Mass spectrometry

KW - Pharmacokinetics

KW - Silver distribution in tissues

KW - Silver-based complex

UR - http://www.scopus.com/inward/record.url?scp=84930661962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930661962&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84930661962

VL - 7

SP - 41

EP - 43

JO - International Journal of Pharmacy and Pharmaceutical Sciences

JF - International Journal of Pharmacy and Pharmaceutical Sciences

SN - 0975-1491

IS - 6

ER -